YI7
(3aM,9S,15R)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4',3':9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid
| Created: | 2023-06-19 |
| Last modified: | 2024-06-19 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 94 |
| Chiral Atom Count | 1 |
| Bond Count | 100 |
| Aromatic Bond Count | 26 |
Chemical Component Summary | |
|---|---|
| Name | (3aM,9S,15R)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4',3':9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid |
| Systematic Name (OpenEye OEToolkits) | n/a |
| Formula | C39 H44 Cl F N4 O5 |
| Molecular Weight | 703.242 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | Fc1ccc2c(c1)cccc2OCCCc1c2ccc(Cl)c3c4c(CC)n(C)nc4C(CCN4CCOCC4)OCCCCn(c1C(=O)O)c23 |
| SMILES | CACTVS | 3.385 | CCc1n(C)nc2[CH](CCN3CCOCC3)OCCCCn4c(C(O)=O)c(CCCOc5cccc6cc(F)ccc56)c7ccc(Cl)c(c47)c12 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CCc1c-2c(nn1C)C(OCCCCn3c4c2c(ccc4c(c3C(=O)O)CCCOc5cccc6c5ccc(c6)F)Cl)CCN7CCOCC7 |
| Canonical SMILES | CACTVS | 3.385 | CCc1n(C)nc2[C@@H](CCN3CCOCC3)OCCCCn4c(C(O)=O)c(CCCOc5cccc6cc(F)ccc56)c7ccc(Cl)c(c47)c12 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CCc1c-2c(nn1C)[C@H](OCCCCn3c4c2c(ccc4c(c3C(=O)O)CCCOc5cccc6c5ccc(c6)F)Cl)CCN7CCOCC7 |
| InChI | InChI | 1.06 | InChI=1S/C39H44ClFN4O5/c1-3-31-35-34-30(40)14-13-29-28(9-7-21-49-32-10-6-8-25-24-26(41)11-12-27(25)32)38(39(46)47)45(37(29)34)16-4-5-20-50-33(36(35)42-43(31)2)15-17-44-18-22-48-23-19-44/h6,8,10-14,24,33H,3-5,7,9,15-23H2,1-2H3,(H,46,47)/t33-/m1/s1 |
| InChIKey | InChI | 1.06 | RQXSLNDYCDRXAC-MGBGTMOVSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB23607 |
|---|---|
| Name | BRD-810 |
| Groups | experimental |
| Description | BRD-810 is an experimental small molecule being investigated as a potential anti-cancer medication. It is an inhibitor of the protein myeloid cell leukemia 1 (MCL1). [A274263] |
| Synonyms | BRD-810 |
| CAS number | 2329719-65-3 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Induced myeloid leukemia cell differentiation protein Mcl-1 | MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGG... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 142591867 |
